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PROSTIGMINE IN ACUTE ANTERIOR
POLIOMYELITIS*
MALCOLM S. EVELETH AND ALLAN J. RYAN
In a recent article byKabat and Knapp,' the use ofprostigmine in
thetreatment ofpoliomyelitis has been discussed. Theirapproach to
therapy wasbased on the Kennyconcept ofthe disease. From obser-
vations on a series of 20 patients with poliomyelitis, most of whom
were in the subacute stage of the disease, it was concluded that pros-
tigmine increased the range of passive motion, decreased or elim-
inated deformities in some instances by relaxation of hypertonus, and
in a few cases improved the active motion. Hot fomentations were
used duringthe time that the drug was administered.
From June through November 1943 we have had an opportunity
of seeing nearly 200 cases of acute poliomyelitis in the New Haven
Hospital. In view of the improvement noted by Kabat and Knapp
with prostigmine we felt justified in trying this drug on a small
selected group of our cases. The Kenny method was used in the
treatment of all our patients. Ultimately 12 patients in the early
stages of the disease received prostigmine as an additional form of
therapy.
The 12 patients whom we chose all showed marked spasm of the
back muscles and hamstrings, and 10 of these had some degree of
paralysis in the legs. There were two reasons why we did not have
a control group to compare with those patients treated with prostig-
mine. The first was that the clinical findings in poliomyelitis are
so different in each case that a small series would have little sig-
nificance, while in the second place there were not enough patients
with the same type of involvement who could be counted on to coop-
erate or who would be available for the whole test period.
The essential difference between our series of patients and those
of Kabat and Knapp was that our patients were started on prostig-
mine treatment earlier in the course of the disease. The average
period from the onset of symptoms until prostigmine was given was
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18 days, and thepatientsaveraged twoweeks of theKenny treatment
during this period. In the series of Kabat and Knapp there was an
average period of 6 months before prostigmine was given.
Our procedure was as follows:
(1) The range of passive motion of the involved extremity was
measured in degrees using the goniometer.
(2) A subcutaneous injection of prostigmine methylsulfate was
given.
(3) The range of motion was again measured after one hour.
(4) Routine Kenny treatment was then resumed.
(5) Prostigmine was given orally, three times a day for 28
days.
(6) The range of passive motion was measured for the third
time.
The dosages of prostigmine, and of atropine when it was given,
were approximately the same as those used by Kabat and Knapp.
A subcutaneous dose of 1.5 mg. of prostigmine methylsulfate and
0.6 mg. of atropine sulfate was given to the adults. Older children
were given 1.125 mg. of prostigmine and 0.4 mg. of atropine.
Younger children were given 0.5 mg. of prostigmine and no atro-
pine. No Kenny packs were given during the hour following the
subcutaneous dose. The oral doses of prostigmine bromide were
started at roughly one-third the average maximum dose for the
patient's age and were rapidly increased to tolerance. The average
adult dose was 45 mg. of prostigmine bromide and 0.6 mg. of atro-
pine given orally three times a day. The two small children were
each given 30 mg. three times a day without atropine. The largest
total oral dose of prostigmine given an adult during the 28-day
period was 3.24 gm., the smallest 2.3 gm. The largest total
dose given a child was 2.68 gm., the smallest 1.87 gm.
The immediate reactions to a test dose of prostigmine glven
subcutaneously were similar to those noted by Kabat and Knapp.
All 12 patients had fascicular muscle twitchings within one-half
hour after the injection. Eight had mild twitchings while four
had severe ones. These had disappeared by the end of one hour.
Two patients complained of a feeling of numbness at the base
of the tongue. Two had some mild abdominal pain, two had
nausea and one of these vomited. The child who vomited was a
7-year-old girl who had received 1.1 mg. of prostigmine and 0.4
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A.L. M 15 5 A 144 142
B 18 2
C -6 -13
D -24 -15
R.C. M 16 7 A 122 145
B 2 15
C -18 5
D -20 -10
F.C. M 3 10 A 155 140
B 25 10
C 16 16
D -9 6
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B 10 1
C 34 11
D 24 10
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C 18 19
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A = Range of passive motion in degrees before subcutaneous prostigmine.
B = Increa-se or decrease of motion 1 hr. after subctaneous prostigmine.
C =Increase or decrease of motion 28 days after oral prostigmine was started.
D = Increase or decrease during oral prostigmnine alone.34YALE JOURNAL OF BIOLOGY AND MEDICINE
mg. of a;tropine subcutaneously-in retrospect too large a dose
for a child of this age.
One patient developed hematuria on the twenty-third day of
treatment and the drug was discontinued. Two days later she
had no gross or microscopic blood in the urine and has had none
since. This patient was a 27-year-old female who was four months
pregnant at the time. She had had two previous pregnancies with-
out complications and had never before had hematuria. This was
the only patient who received less than the 28-day period of therapy
with prostigmine.
Onepatient, whopreviously had been completely unable to move
one lower extremity was able to bend his knee one hour after the
injection of prostigmine.
Within a few days after the onset of prostigmine therapy the
adult patients volunteered the information that they could move
about in bed more freely and had a subjective feeling of more
strength in performing purposeful motions. An example of this
was one patient, an adult female, who one week after the begin-
ning of treatment was able to turn over in bed by herself, whereas
she hadpreviouslybeen unable to do so.
Table 1 shows the changes in the range of passive motion that
were found in these patients. It can be seen from these figures
that the most marked increase in passive motion occurred one hour
after the initial subcutaneous injection of prostigmine. In general,
there was not so marked an improvement after the 28-day period of
oral therapy, even though the Kenny treatment was being carried on
duringthis period. Itcanbe seenthat the changes varyconsiderably
in the different muscle groups; this same phenomenon was noted by
Kabat and Knapp in their series.
Two ofour adult patients were given a second subcutaneous dose
of the drug two weeks after the first injection. The range of
motion was then measured one hour later, just as after the initial
injection. This was done to see if the subcutaneous injection was
more effective than the oral method. Table 2 shows that this
second injection did not have much effect in these two patients and
suggests that the improvement obtained by the first subcutaneous
dose could probably be maintained just as well by the oral as by the
subcutaneous administration of the drug.
In order to attempt a comparison of our results with those of
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TABLE 2
A COMPARISON, MEASURED IN DEGREES, OF THE EFFECT OF T'HE FIRST AND SECOND
SUBCUTANEOUS INJECTIONS (TWO-WEEK INTERVAL) IN INCREASING THE
RANGE OF PASSIVE MOTION
3) .2 %W i2t
R L R L R L R L R L Both
D.M. 1st 16 7 13 15 13 12 1 6 2 1 3
2nd 6 -4 11 -9 -4 -19 2 6 1 -3 -1
M.G. 1st 17 10 16 10 22 10 7 7 14 13 -2
2nd -3 4 -10 1 -5 -7 5 0 8 4 0
Kabat and Knapp we chose 12 of their patients who had an average
period of prostigmine treatment of about 4. weeks. These 12
patients were started on prostigmine treatment after an average of
4 months after the onset of symptoms. Table 3 shows the results
of this comparison.
TABLE 3
AVERAGE RANGE OF PASSIVE MOTION AND CHANGE IN RANGE OF MOTION,
MEASURED IN DEGREES.
(The 12 patients in this series are compared with 12 patients from the series of
Kabat and Knapp also treated with oral drug for an average period of 4 weeks.)
Dorsi- Dosri-
Straight Knee flexion flexion
leg Knee flexion foot, knee foot, knee Abduction
raisi-ng flexion prone straight flexed legs
E& K&Kt R&R K&K E&R K&K E&R K&K E&R K&K E&R K&K
Originalrange
of passive
motionbefore
prostigmine 147 ... 78 ... 76 ... 97 ... 86 ... 72...
Change after
subcutaneous
dose 9 13 15 7 10 26 4 5 3 4 4 12
Change after
28 days 13 21 25 21 12 13 3 11 4 10 -7 18
Effect of
oa idrug 4 8 10 14 2 -13 -1 6 1 6 -11 6
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Table 4 was drawn up in an effort to compare the number of
patients in our series with the number of patients from among the
12 that we selected from the series of Kabat and Knapp who
showed improvement or regression in passive motion while under
prostigmine therapy.
TABLE 4
NUMBER OF PATIENTS IN THIS SERIES AND IN THAT OF KABAT AND KNAPP SHOWING
IMPROVEMENT OR OTHERWISE AFTER SUBCUTANEOUS AND ORAL
ADMINISTRATION OF PROSTIGMINE
(The figures in the second row "after 28 days" indicate the number of patients who
showed a greater range of passive motion than before prostigmine. The figures in
the bottom line indicate the number of patients showing a further increase in passive
motion due to oral administration of the drug after the initial effect from the
subcutaneous drug had been obtained.)
General Partial No General Partial
improvement improvement change regression regression
E&R K&K E&R K&K E&R K&K E&R K&K E&R K&K
Af-ter initial subcu-
taneDus dose .... 8 9 4 3 ... ... ... ... ... ...
After 28 days ..... 5 10 4 1 ... 1 2 ... 1 ...
Effect oforal drug 2 4 4 4 ... 1 4 1 2 2
Summary and conclusions
1. We have treated a series of 12 patients having acute anterior
poliomyelitis with prostigmine, in addition to the Kenny form of
therapy.
2. An effort has been made to compare our results with those
of Kabat and Knapp.
3. There was a definite relief of muscle spasm, as indicated by
an increased range ofpassive motion, in the lower extremities follow-
ing the initial subcutaneous injection of prostigmine methylsulfate.
This decrease in spasm occurred in all 12 patients and was recorded
one hour after the injection. During this hour no packs were used.
4. The difficulty in determining the effect of the oral adminis-
tration of prostigmine on muscle spasm after the 4-week period is
obvious. These patients might have had a decrease in muscle spasm
without any therapy during this period or the hot packs may have
relieved the spasm. In any event, after a period of 4 weeks of
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prostigmine given orally, therewas, ingeneral, little furtherdecrease
in spasm. Six of the twelve cases showed less spasm.
5. In the series of Kabat and Knapp there was a more marked
improvement following the oral drug than in our patients. How-
ever, ours were started on prostigmine much earlier in the course
of the disease than were those of Kabat and Knapp and this fact may
account for the difference.
6. We were not able to note the effect of prostigmine in con-
tractures because our patients were all in the early stage of the
disease.
7. A period of about 8 months has elapsed since this study was
made and these patients have continued to receive the Kenny treat-
ment without prostigmine. They have shown a gradual relief of
muscle spasm and in most cases an improvement in musde power.
Whether or not in the long run this relief was facilitated by pros-
tigmine is difficult to determine.
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